Monocyte chemotactic protein (MCP3) promoter polymorphism is associated with atopic asthma in the Indian population

  • Jyotsna Batra*
  • , Sudipta Das
  • , Rajshekhar Chatterjee
  • , Sunandini Chandra
  • , Balaram Ghosh
  • *Corresponding author for this work

Research output: Contribution to journalLetterResearchpeer-review

Abstract

Monocyte chemotactic protein (MCP3) 3 interacts with several CC chemokine receptors expressed on various leukocyte subpopulations, thus activating crucial effector cells involved in asthma pathogenesis. MCP3 mRNA expression was found to be significantly increased in the bronchial mucosa of atopic and nonatopic asthmatic subjects. Additionally, MCP3 levels were significantly increased in bronchoalveolar lavage fluid of asthmatic subjects and associated with increased accumulation of bronchial mucosal eosinophils.
Original languageEnglish
Pages (from-to)239-242.e3
Number of pages4
JournalJournal of Allergy and Clinical Immunology
Volume128
Issue number1
DOIs
Publication statusPublished - Jul 2011
Externally publishedYes

Fingerprint

Dive into the research topics of 'Monocyte chemotactic protein (MCP3) promoter polymorphism is associated with atopic asthma in the Indian population'. Together they form a unique fingerprint.

Cite this